122 related articles for article (PubMed ID: 8707926)
1. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
Vedeler CA; Matre R; Sadallah S; Schifferli J
J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
[TBL] [Abstract][Full Text] [Related]
2. The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndrome.
Patzold T; Sindern E; Ossege-Pohle L; Malin JP
J Neurol; 1998 Dec; 245(12):803-8. PubMed ID: 9840353
[TBL] [Abstract][Full Text] [Related]
3. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-I (sICAM-I) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system.
Trojano M; Avolio C; Ruggieri M; De Robertis F; Giuliani F; Paolicelli D; Livrea P
Mult Scler; 1998 Feb; 4(1):39-44. PubMed ID: 9532592
[TBL] [Abstract][Full Text] [Related]
5. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.
Hartung HP; Hughes RA; Taylor WA; Heininger K; Reiners K; Toyka KV
Neurology; 1990 Feb; 40(2):215-8. PubMed ID: 2300238
[TBL] [Abstract][Full Text] [Related]
6. Neuroimmunological findings in Guillain Barré syndrome, multiple sclerosis, and idiopathic polyneuropathies.
Dorta-Contreras A; Silva-Somoza R
Mol Chem Neuropathol; 1996; 28(1-3):279-84. PubMed ID: 8871970
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid and serum antiphospholipid antibodies in multiple sclerosis, Guillain-Barré syndrome and systemic lupus erythematosus.
Marchiori PE; Dos Reis M; Quevedo ME; Callegaro D; Hirata MT; Scaff M; De Oliveira RM
Arq Neuropsiquiatr; 1990 Dec; 48(4):465-8. PubMed ID: 2094193
[TBL] [Abstract][Full Text] [Related]
8. Little change in cerebrospinal fluid amino acids in subtypes of multiple sclerosis compared with acute polyradiculoneuropathy.
Gårseth M; White LR; Aasly J
Neurochem Int; 2001 Aug; 39(2):111-5. PubMed ID: 11408089
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Maimone D; Annunziata P; Simone IL; Livrea P; Guazzi GC
J Neuroimmunol; 1993 Aug; 47(1):55-61. PubMed ID: 8376548
[TBL] [Abstract][Full Text] [Related]
10. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients.
Ghabaee M; Jabedari B; Al-E-Eshagh N; Ghaffarpour M; Asadi F
Int J Neurosci; 2010 Apr; 120(4):301-4. PubMed ID: 20374079
[TBL] [Abstract][Full Text] [Related]
12. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
[TBL] [Abstract][Full Text] [Related]
13. Serum and CSF levels of soluble interleukin-2 receptors in MS and other neurological diseases: a reappraisal.
Chalon MP; Sindic CJ; Laterre EC
Acta Neurol Scand; 1993 Feb; 87(2):77-82. PubMed ID: 8442399
[TBL] [Abstract][Full Text] [Related]
14. [Detection of interleukin-6 in serum and cerebrospinal fluid of patients with neuroimmunological diseases].
Shimada K; Koh CS; Yanagisawa N
Arerugi; 1993 Aug; 42(8):934-40. PubMed ID: 8250733
[TBL] [Abstract][Full Text] [Related]
15. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system.
Kastenbauer S; Koedel U; Wick M; Kieseier BC; Hartung HP; Pfister HW
J Neuroimmunol; 2003 Apr; 137(1-2):210-7. PubMed ID: 12667665
[TBL] [Abstract][Full Text] [Related]
16. Analyses of transthyretin concentration in the cerebrospinal fluid of patients with Guillain-Barré syndrome and other neurological disorders.
Chiang HL; Lyu RK; Tseng MY; Chang KH; Chang HS; Hsu WC; Kuo HC; Chu CC; Wu YR; Ro LS; Huang CC; Chen CM
Clin Chim Acta; 2009 Jul; 405(1-2):143-7. PubMed ID: 19410571
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor and interleukin-1 in the CSF and sera of patients with multiple sclerosis.
Tsukada N; Miyagi K; Matsuda M; Yanagisawa N; Yone K
J Neurol Sci; 1991 Aug; 104(2):230-4. PubMed ID: 1940977
[TBL] [Abstract][Full Text] [Related]
18. Cyclic guanosine monophosphate (cGMP), nitrite and nitrate in the cerebrospinal fluid in meningitis, multiple sclerosis and Guillain-Barré syndrome.
Ikeda M; Sato I; Matsunaga T; Takahashi M; Yuasa T; Murota S
Intern Med; 1995 Aug; 34(8):734-7. PubMed ID: 8563111
[TBL] [Abstract][Full Text] [Related]
19. Extra- and intrathecal production of antinerve and antibrain antibodies in Guillain-Barré syndrome: evaluation by an antibody index.
Ryberg B
Neurology; 1984 Oct; 34(10):1378-81. PubMed ID: 6541314
[TBL] [Abstract][Full Text] [Related]
20. Guillain-Barré syndrome: activated complement components C3a and C5a in CSF.
Hartung HP; Schwenke C; Bitter-Suermann D; Toyka KV
Neurology; 1987 Jun; 37(6):1006-9. PubMed ID: 3495747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
